May 7, 2024Open Access

Liver Observation Segmentation on Contrast-Enhanced MRI: SAM and MedSAM Performance in Patients With Probable or Definite Hepatocellular Carcinoma

Key Points

Key points are not available for this paper at this time.

Abstract

To evaluate factors impacting the Segment Anything Model (SAM) and variant MedSAM performance for segmenting liver observations on contrast-enhanced (CE) magnetic resonance imaging (MRI) in high-risk patients with probable hepatocellular carcinoma (HCC) (LR-4) and definite HCC (LR-5).

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper

Cite This Study

Saha et al. (Tue,) studied this question.

synapsesocial.com/papers/68e6b299b6db64358763424b https://doi.org/https://doi.org/10.1177/08465371241250215

KI fragen

Bookmark

View Full Paper